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Available online 8 August 2017Fetal hemoglobin (HbF) and peripheral hemoglobin oxygen saturation (SpO2) both predict clinical severity in
sickle cell disease (SCD), while reticulocytosis is associated with vasculopathy, but there are few data on mech-
anisms. HbF, SpO2 and routine clinical and laboratorymeasureswere available in a Tanzanian cohort of 1175 SCD
individuals aged ≥ 5 years and the association with SpO2 (as response variable transformed to a Poisson distribu-
tion) was assessed by negative binomial model with age and sex as covariates. Increase in HbF was associated
with increased SpO2 (rate ratio, RR = 1.19; 95% conﬁdence intervals [CI] 1.04, 1.37 per natural log unit of HbF;
p = 0.0004). In univariable analysis, SpO2 was inversely associated with age, reticulocyte count, and log (total
bilirubin) and directly with pulse, SBP, hemoglobin, and log(HbF). In multivariable regression log(HbF) (RR
1.191; 95%CI 1.04, 1.37; p = 0.013), pulse (RR 1.01; 95%CI 1.00, 1.01; p = 0.026), SBP (RR 1.008; 95%CI 1.00,
1.02; p = 0.014), and hemoglobin (1.120; 95%CI 1.05, 1.19; p= 0.001) were positively and independently asso-
ciated with SpO2 while reticulocyte count (RR 0.985; 95%CI 0.97, 0.99; p = 0.019) was independently inversely
associated with SpO2. In SCD, improving SpO2, in part through cardiovascular compensation and associated with
reduced reticulocytosis, may be a mechanism by which HbF reduces disease severity.gy and Blood Transfu
pen access article und© 2017 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Fetal hemoglobin (HbF)
Sickle cell disease
Hypoxia
Oxygen saturation
Reticulocytes1. Introduction
Sickle cell disease (SCD) remains the most common hemoglobinop-
athyworldwide. Clinically, there is great variability amongst individuals
with SCD; predictors of severity include hemoglobin F levels,
reticulocytosis and alpha globin gene number. A major factor is the
wide variation in the innate ability to synthesize fetal hemoglobin
(HbF) beyond early childhood. Individuals with high levels of HbF expe-
rience milder forms of the disease with lower morbidity and improved
survival. HbF level of 10% and above is believed to reduce the risk of
major organ failure such as stroke, while much higher levels (20% and
above) may be required to prevent recurrent clinical events such assion, P. O.
er the CC BY-Npainful crises and pulmonary disorder (Meier et al., 2017). The mecha-
nisms underlying the reduction in the severity of SCD in people with
high HbF are not clear. Therefore, studying the associations of HbF and
clinical phenotypes of SCD may provide insights into the underlying
mechanisms.
Peripheral hemoglobin oxygen saturation (SpO2), measured non-
invasively by pulse oximetry, is related to several disease complications.
Lower SpO2 has been associated with anemia (Quinn and Ahmad,
2005), increase in reticulocytes (Quinn and Ahmad, 2005), hemolysis
(Campbell et al., 2009) and increased episodes of acute chest syndrome
(Rackoff et al., 1993) and appears to predict central nervous system
complications (including stroke (Quinn and Sargent, 2008), higher
transcranial doppler velocity (Quinn et al., 2009), number of days per
year admitted for pain (Hargrave et al., 2003), tricuspid regurgitant jet
velocity (TRV) (Minniti et al., 2009) and diastolic dysfunction
(Johnson et al., 2010) in SCD.C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Distribution of SpO2 before (A) and after (B) transformation. Conversion of the
distribution of SpO2 (Fig. 1A) into a Poisson distribution, 100-SpO2 transformation was
performed resulting in the distribution shown in Fig. 1B.
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cending to high altitude suggest that HbF synthesis increases in hypoxia
(Bard et al., 1994). Furthermore, hemolysis may induce HbF synthesis
further (Desimone et al., 1978). There is limited information on the
magnitude and direction of any association between HbF and SpO2 in
patients with SCD not on hydroxyurea, but the available data suggest
that, as for neonates (Shiao, 2005), SpO2 is higher in SCD patients with
higher HbF (Homi et al., 1997), (Halphen et al., 2014, Cox et al., 2013).
In this report, we describe the association between HbF and SpO2 in in-
dividuals with SCD enrolled in the Muhimbili National Hospital cohort
in Tanzania.
2. Materials and Methods
2.1. Study Area and Population
This was a cross sectional study conducted at Muhimbili National
Hospital (MNH) in Dar-es-Salaam, Tanzania involving individuals with
SCD recruited into the Muhimbili Sickle cohort between March 2004
and December 2013. Recruitment and enrolment of patients and diag-
nosis of SCD has been previously described (Makani et al., 2011). In-
formed consent was obtained for each patient upon enrolment.
Individuals were identiﬁed at pediatric SCD or hematology clinics or
during hospitalization and were screened for SCD. A diagnosis of sickle
cell anemia (HbSS/HbSβ0) by alkalinehemoglobin electrophoresis (Hel-
ena, Sunderland, Tyne&Wear, UK)was conﬁrmed by high performance
liquid chromatography (HPLC) (Variant I analyzer, Bio-Rad, Hercules,
CA, USA). Ethical approval was granted by theMuhimbili University Re-
search and Publications Committee (MU/RP/AEC/VOLX1/33).
Individuals were selected into this study if they had HbF valuesmea-
sured at the age of ﬁve years or above, since this is the age at which HbF
synthesis stabilises. Data were excluded if the patient was on hydroxy-
urea therapy.
2.2. Clinical Measures
Daytime SpO2 was determined in clinic when the child was well
using a pulse oximeter (Nellcor, Pleasanton, CA, USA). Other clinical in-
formation thatwas collected included pulse rate, systolic blood pressure
(SBP), and diastolic blood pressure (DBP).
2.3. Laboratory Measures
Hemoglobin was measured by an automated blood cell analyser
(ABX Pentra 60 Analyser, Horiba, Kyoto, Japan) and reticulocytes were
counted using the new methylene blue staining method followed by
microscopy. HbF measurements were done by HPLC (Variant I, Biorad,
Hercules, CA, USA). Routine biochemical analysis included total biliru-
bin (Roche Cobas Mira, New York, USA or Abbott Architect, New York,
USA).
2.4. Statistical Methods
The SpO2 data were collected as counts, which ranged from 82 to
100%, and could not be transformed into a normal random distribution,
and hence a Poisson random distribution was assumed after transfor-
mation. To convert the distribution of SpO2 (Fig. 1A) into a Poisson dis-
tribution, 100-SpO2 transformation was performed, Fig. 1B. The
distributions of HbF and bilirubin were positively skewed and hence
normalized by natural log transformation. The association of clinical
and laboratory variables with SpO2 (as response variable) was assessed
by negative binomial model with age and sex included as covariates,
presenting the results as rate ratio (RR) with 95% conﬁdence intervals.
A p-value b 0.05 was considered statistically signiﬁcant. Variables with
signiﬁcant associations with SpO2 in the univariate analysis were in-
cluded in the multivariable regression analysis.3. Results
We investigated 1175 individuals (52.1% female, median age 11.2
[IQR: 7.9–16.7] years) with both HbF and SpO2 measurements. Median
HbF was 4.4% [IQR: 2.4–7.2] and median SpO2 was 98% [IQR: 96–99].
Table 1 shows the results for the univariable andmultivariable analyses.
The distribution of HbF in relation to SpO2 is presented in Fig. 2; which
shows the increase in oxygen saturation by one unit is associated with
increase in mean of log(HbF) by 0.031 (95%CI: 0.013, 0.049), p =
0.020) while other variables are held constant (Table 1). In univariable
analysis, SpO2 was directly associated with pulse rate, systolic blood
pressure (SBP), hemoglobin, and log(HbF) and inversely with age, retic-
ulocyte count, and log (total bilirubin) (Table 1). In multivariable re-
gression, log(HbF), pulse rate, SBP, and hemoglobin were positively
and independently associated with SpO2, while reticulocyte count was
inversely and independently associated with SpO2 (Table 1).
4. Discussion
This study reports the association of HbF with SpO2 in individuals
with SCD. The study involves one of the largest single-centre SCD popu-
lation to date and the ﬁrst study to be conducted in an African popula-
tion where the environment is different. This population is composed
of a Central African Republic (CAR) sickle haplotype of predominatly
βS/βS genotype, a genetic background associated with a more severe
disease. In addition, the population under study is hydroxyurea naïve
and there are limited resources for interventions. These factors make
it pertinent for the study to be conducted in this population in order
to identify disease-modifying factors that may be amenable to treat-
ment. We have conﬁrmed the association between HbF and SpO2
(Homi et al., 1997). Both HbF and total hemoglobin (Hb) were associat-
ed with SpO2 independently suggesting that there may be separate
mechanisms by which increasing Hb and HbF improve SpO2. The asso-
ciation between HbF and SpO2 should augment efforts to develop and
evaluate interventions that increase both HbF and SpO2. Although the
mechanism of this association is not known, the oxygen dissociation
curve properties for HbS and HbF are different. Therefore, the decreased
oxygen afﬁnity of hemoglobin S (Ueda et al., 1979) may partially con-
tribute to the low SpO2 in SCD. On the other hand, higher levels of
Table 1
Association between SpO2(%) and clinical and laboratory parameters in sickle cell disease.
Parameters SpO2 (%) univariable SpO2 (%), multivariable, N = 632
N RR 95%CI P RR 95%CI P
Age (years) 1175 0.99 0.89, 0.99 0.024 0.99 0.98, 1.01 0.422
Sex 1175 0.93 0.83, 1.04 0.191 0.91 0.78, 1.07 0.265
Pulse rate (beats/min) 1170 1.00 1.00, 1.01 0.020 1.01 1.00, 1.01 0.026
Systolic blood pressure (mm Hg) 1167 1.01 1.00, 1.01 0.009 1.008 1.00, 1.02 0.014
Log(HbF [%]) 1175 1.19 1.08, 1.31 0.0004 1.191 1.04, 1.37 0.013
Hemoglobin (g/dL) 1136 1.07 1.07, 1.12 0.001 1.120 1.05, 1.19 b0.001
Reticulocyte count (×109/L) 661 0.99 0.98, 1.00 0.043 0.985 0.97, 0.99 0.019
Log(Bilirubin total [mg/dl]) 228 0.65 0.54, 0.77 b0.001
Bolded values represent signiﬁcant associations with p values of less than 0.05.
148 S. Nkya et al. / EBioMedicine 23 (2017) 146–149HbF, which has a higher afﬁnity for oxygen, results in a higher SpO2, in
neonates (Shiao, 2005). In addition, compounds, including an aromatic
aldehyde agent, 5-hydoxymethyl-2-furfural (5-HMF, also known as
Aes-103), has been found to increase oxygen afﬁnity of sickle hemoglo-
bin and as a result reducing hypoxia-induced sickling in vitro and pro-
tects sickle cell mice from the effects of hypoxia (Safo and Kato, 2014).
Pulse rate, SBP and hemoglobin were also positively associated with
SpO2 in multivariable analysis. The direct association of hemoglobin
with SpO2 has been described previously and hence conﬁrmed in the
population that we have studied. The direct association of pulse rate
and SBP suggests that one of the mechanisms for maintaining an ade-
quate SpO2 is cardiovascular compensation. The HbF levels for this pop-
ulation are low compared to other populations with different sickle
haplotypes; despite this, an association with SpO2 was established
and can be further examined when interventions to increase HbF are
in place. Treatment trials could examine whether improving SpO2,
with agents that increase HbF or other methods of improving oxygena-
tion, reduce SBP, a risk factor for stroke in adults and children with SCA.
An association between increased hemolysis and low SpO2 has been
reported (Nouraie et al., 2013). In this study, we report an inverse asso-
ciation between SpO2 and total bilirubin and reticulocyte count, which
are markers of hemolysis, on univariate analysis, suggesting higher
SpO2 in the presence of lower hemolysis or conversely, increased hemo-
lysis if SpO2 is lower. The effect of therapies designed to improve SpO2
or reduce hemolysis may determine whether the initiating mechanismFig. 2.Distribution ofmean log(HbF) levels by oxygen saturation. Thedotted line show the
linear ﬁt of the mean levels, which shows positive association with the increase with the
oxy sat. The increase in oxy sat by one unit is associated with increase in mean of
log(HbF) by 0.031 (95%CI: 0.013, 0.049), p = 0.020.for the association involves either low SpO2 or hemolysis. However,
total bilirubin may also reﬂect liver compromise and reticulocytosis
may be related to the response of the bone marrow to non-hemolytic
anemia. On multivariable analysis, the reticulocyte count was indepen-
dently associated with SpO2, which suggests an effect on erythropoiesis
which may or may not involve hemolysis. We could not investigate the
relative importance of hemolysis further as we only had total bilirubin
for one ﬁfth of the patients; future studies should includemeasurement
of indirect bilirubin, as a more speciﬁc marker of hemolysis, in all
patients.
This study reports the association of HbF with SpO2two variables
with strong clinical signiﬁcance in individuals with SCD. The underlying
mechanism of this association and the optimal range for HbF, measures
cardiac function such as blood pressure and pulse, and SpO2 for good
health in SCD needs to be established. This information will aid in the
development and improvement of HbF-augmenting agents. The ﬁnd-
ings from this study may be applied to other SCD populations that
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